Robert Hamilton: A Candid Conversation with Leading Stroke Experts on the Future of Stroke Care
Robert Hamilton, Chief Executive Officer of NeuraSignal, shared on LinkedIn:
”Last weekend in Los Angeles, I had the privilege of bringing together five of the most respected minds in stroke neurology and neurovascular medicine for a weekend of candid conversation about where stroke care stands today and where it needs to go.
We had the pleasure to host:
- Dr. May Nour
- Dr. Thomas Devlin
- Dr. David S Liebeskind
- Dr. Andrei Alexandrov
- Dr. Gregory Walker
What made the weekend valuable was the depth of clinical perspective these physicians brought.
Between them, they’ve built some of the most effective stroke programs in the country/North America, and they’ve each found ways to close the gap between what’s possible and what’s actually happening at the bedside.
For us at NeuraSignal, this is exactly the kind of input that shapes where the platform goes next.
And there’s a lot more to come.
Grateful to everyone who made the trip.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia